FibroGen is currently testing its antibody drug pamrevlumab in clinical trials to determine if it can treat the symptoms of pneumonia in severely ill coronavirus patients.
source
powered by Auto Youtube Summarize
FibroGen is currently testing its antibody drug pamrevlumab in clinical trials to determine if it can treat the symptoms of pneumonia in severely ill coronavirus patients.
source
